Hansson L
Department of Geriatrics, University of Uppsala, Sweden.
Am J Hypertens. 1994 Sep;7(9 Pt 2):82S-83S.
The Captopril Prevention Project (CAPPP) is an ongoing prospective intervention study in 10,800 hypertensive patients in Sweden and Finland. Patients are randomized to treatment with either conventional antihypertensive therapy, ie, diuretics or beta-blockers, or the angiotensin-converting enzyme inhibitor captopril. The purpose of the CAPPP Study is to compare the two therapeutic alternatives with regard to cardiovascular mortality.
卡托普利预防项目(CAPPP)是一项正在瑞典和芬兰对10800名高血压患者进行的前瞻性干预研究。患者被随机分为接受传统抗高血压治疗,即利尿剂或β受体阻滞剂,或血管紧张素转换酶抑制剂卡托普利治疗。CAPPP研究的目的是比较这两种治疗方案在心血管死亡率方面的差异。